Stephanie Becourt

Lille, FR 
Lille, FR 

Overview

Stephanie Becourt practices practicing medicine in Lille, France.

Her clinical expertise encompasses Ovarian Cancer, Breast Cancer, Inflammatory Breast Cancer, Menorrhagia, and Salpingo-Oophorectomy.

She is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Lille, France
Other Locations
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3

15 Total Publications

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.
Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 15, 2026

Frequently Asked Questions about Stephanie Becourt

Is Stephanie Becourt a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Stephanie Becourt is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephanie Becourt participate in research or clinical trials?

Yes. Stephanie Becourt has published 15 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Stephanie Becourt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Becourt's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile